LONDON, March 13, 2026, 14:52 GMT
Reckitt Benckiser ticked up on Friday, lifted by news of a 140,000-share buyback executed on March 12—part of a fresh £540 million tranche kicked off earlier this week. By 14:42 GMT, the shares sat at 5,325 pence, marking a 0.17% gain for the session, according to Cboe Europe estimates.
Timing here isn’t just a detail. The buyback comes just days after Reckitt’s full-year numbers triggered a slide of over 6%—the steepest one-day drop for the stock in nearly a year. Investors zeroed in on uncertain margin and EPS prospects for 2026, brushing aside robust emerging-market sales.
Deutsche Bank is running point on the new tranche, according to a March 9 regulatory filing, with plans to return as much as £540 million by July 27. Shares repurchased in this round will land in treasury instead of being cancelled immediately; earlier tranches delivered £250 million and £206 million back to shareholders.
On March 5, Reckitt projected Core Reckitt would post 4% to 5% like-for-like revenue growth in 2026, adjusting for currency effects and any portfolio shifts. The company flagged a softer cold-and-flu season and a challenging European market, plus hit caution on EPS dilution tied to the Essential Home divestment. Its Fuel for Growth program, meanwhile, is designed to absorb “stranded costs”—the overhead that remains after asset sales. Reckitt
That’s kept investors circling the shares. “The margin benefit from the divestiture of essential home is being offset by stranded costs and FX,” said Quilter Cheviot analyst Chris Beckett, flagging the drag from foreign exchange after the results. Reuters
Emerging markets remain central to management’s optimism. Chief Executive Kris Licht called these regions a “must-win” for the company, following stronger-than-expected 2025 core like-for-like revenue growth of 5.2%—driven by China and India—which topped Reckitt’s stated 4% to 5% medium-term range. Reuters
Reckitt finds itself following a well-worn path. The maker of Durex has been trimming its slower-growing businesses, much like Unilever and Nestle, and shifting focus to brands with fatter margins. Disposals, though, can leave some cost overhangs showing before any efficiency gains start to appear.
The risk is hard to miss here. Europe could stay sluggish, price wars might drag on, and with the cold-and-flu season turning out mild, the group could see little first-quarter support. CEO Licht was blunt with analysts: “Europe will likely remain tough.” CFO Shannon Eisenhardt, for her part, made it clear that 2026 margin progress hinges on “how much of those stranded costs we offset within 2026.” Reckitt
Mead Johnson Nutrition remains unresolved. Reckitt is projecting low-single-digit like-for-like growth for 2026, following a mid-single-digit drop in the first quarter. The group hasn’t ruled out any strategic moves for the business yet; that review is ongoing. After a modest uptick on Friday, shares finished the week 4.6% lower across five sessions.
